Skip to content
Medical Health Aged Care

RegenLab France Receives Prestigious EU-EIB Innovation Champion Award

RegenLab 2 mins read
PARIS-SACLAY, France--BUSINESS WIRE--

RegenLab, a pioneering biotechnology company specializing in the research, development, and manufacturing of patented cell and tissue engineering medical devices, has been honored with the “Innovation Champion Award” by the European Investment Bank (EIB) at the European Convention Center in Luxembourg.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611846846/en/

RegenLab France receives prestigious EU-EIB Innovation Champion Award. Antoine Turzi, CEO and Founder of RegenLab, pictured between two officials of the European Investment Bank. (Photo: Business Wire)

RegenLab France receives prestigious EU-EIB Innovation Champion Award. Antoine Turzi, CEO and Founder of RegenLab, pictured between two officials of the European Investment Bank. (Photo: Business Wire)

This prestigious award recognizes RegenLab France’s commitment to “reshoring” by establishing a state-of-the-art biotechnology factory in Paris-Saclay and its innovation, the REGENMATRIX® PRP-HA. This next-generation product combines Platelet-Rich Plasma (PRP) with cross-linked Hyaluronic Acid (HA) in a single tube, designed specifically to address the needs of patients with advanced grade III-IV knee osteoarthritis. Currently, a clinical study is underway in 16 university hospitals across France to demonstrate the effectiveness and safety of this groundbreaking treatment.

We are honored and delighted to receive this award from the European Investment Bank,” said Mr. Antoine Turzi, Founder & CEO of RegenLab France. “This recognition celebrates the successful completion of our French factory and our ongoing R&D efforts. Our goal is to innovate in cell therapies and enhance the well-being of patients, while supporting industry reshoring in France.”

RegenLab’s achievement not only highlights its dedication to advancing medical science but also underscores the pivotal role of the EIB in promoting innovation, its sustainable growth across Europe and its competitiveness worldwide.

About RegenLab

Based in Paris Saclay, RegenLab France is a company specialized in the R&D and manufacturing of tissue engineering medical devices supported by 100 patents. The Company’s solutions are commercialized in more than 90 countries. The core technology of the Company is manufacturing of medical devices for autologous platelet-rich plasma (PRP) & Tissue Engineering, consisting in reinjecting the patient’s own cells and platelets into tissue lesions in order to stimulate tissue healing. The RegenKit, CellularMatrix… brands,  have been CE marked EU-MDR 2017/745 and approved by US-FDA, CFDA & worldwide regulatory agencies;  they are routinely used for the treatment of a wide variety of indications including joint osteoarthritis, tendinopathies, woman health and dermo-aesthetics. The Company’s medical devices are also manufactured in the factory of Le Mont-sur-Lausanne (Switzerland) & New York (USA).


Contact details:

RegenLab France SAS | +33 1 77 44 60 60 | info@regenlab.com
Antoine Turzi | C.E.O.
Hubert de Pombriant I General Manager
Jean-Marc Biscarrat | Chief Financial Officer

Media

More from this category

  • Medical Health Aged Care
  • 24/07/2024
  • 18:40
Malaysia Healthcare Travel Council

Malaysia Healthcare Travel Council Launches Experience Malaysia Healthcare (EMH) Stories

KUALA LUMPUR, Malaysia, July 24, 2024 (GLOBE NEWSWIRE) -- Malaysia Healthcare Travel Council (MHTC) is proud to announce the premiere of EMH Stories, a limited-series video production showcasing the exceptional experience of the healthcare journey of healthcare professionals, patients and technology breakthrough within Malaysia's healthcare travel ecosystem.Experience Malaysia Healthcare (EMH) Stories is designed to provide an intimate and inspiring glimpse into the diverse and impactful stories within Malaysia's healthcare travel ecosystem. The series aims to demonstrate the expertise and specialization within Malaysia’s healthcare system, build the reputation and credibility of Malaysia's healthcare services, and increase awareness and visibility of the…

  • Medical Health Aged Care, Research Development
  • 24/07/2024
  • 15:46
National Rural Health Alliance

Changes to Patient Travel Subsidy Scheme will benefit rural patients

The removal of the Patient Travel Subsidy Scheme’s four-night rule by the Queensland government is applauded by the National Rural Health Alliance (the Alliance). Rural Queenslanders will no longer need to cover the first four nights of accommodation out of pocket from 1 August. This initiative will save Queenslanders who need to travel to access healthcare, hundreds of dollars, which add to the other costs of living and working outside of urban centres. “This is timely and necessary news for rural populations in Queensland,” said the Alliance Chief Executive Susi Tegen. “Many rural patients must travel over 50kms from their…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/07/2024
  • 15:17
Dementia Australia

Dementia Australia awards $385,000 to support dementia-friendly projects

Dementia Australia has awarded more than $385,000 in grants to support 27 communities across Australia to become more dementia-friendly. Each of the 27 community groups were awarded up to $15,000 to fund dementia-friendly initiatives tailored to the issues and opportunities in their area. Dementia Australia Executive Director Services, Advocacy & Research Dr Kaele Stokes said one of the keys to the success of such initiatives was that grant recipients would work closely with local people living with dementia. “We know that discrimination and social isolation have a big impact on people living with dementia,” Dr Stokes said. “With more than…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.